Patents by Inventor Nicholas Moore

Nicholas Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160095829
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of a TRPV1 compound (e.g., capsaicinoid compound) at or near a target site, one can relieve pain caused by diverse sources, including but not limited to, postoperative pain, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 7, 2016
    Inventors: Nicholas A. Moore, Danielle L. Clay
  • Publication number: 20160083359
    Abstract: 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
    Type: Application
    Filed: November 23, 2015
    Publication date: March 24, 2016
    Inventors: Benny Bang-Andersen, André Faldt, Arne Mørk, Heidi Lopez De Diego, René Holm, Tine Bryan Stensbøl, Lone Munch Ringgard, Michael J. Mealy, Michael Harold Rock, Jørgen Brodersen, Morten Jørgensen, Nicholas Moore
  • Patent number: 9211274
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of a TRPV1 compound (e.g., capsaicinoid compound) at or near a target site, one can relieve pain caused by diverse sources, including but not limited to, postoperative pain, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: December 15, 2015
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Nicholas A. Moore, Danielle L. Clay
  • Publication number: 20150114099
    Abstract: A direct injection, solenoid fuel injector includes at least one current sensing function capable of detecting a current draw of the solenoid and a controller function. The controller is capable of determining a fully open time of the direct fuel injector solenoid based on the application of a slope inflection filter and a slope discrimination filter to a derivative of the current draw.
    Type: Application
    Filed: October 15, 2014
    Publication date: April 30, 2015
    Inventors: Ningsheng Qiao, Nicholas Moore, Francois Fabre
  • Publication number: 20150005318
    Abstract: This disclosure relates to a method of treating a disease selected from the group consisting of Alzheimer's disease, cognitive impairment, and attention deficit hyperactivity disorder (ADHD). The method includes administering a therapeutically effective amount of Compound I or a pharmaceutically acceptable salt thereof to patient in need thereof, in which Compound I is 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine.
    Type: Application
    Filed: September 9, 2014
    Publication date: January 1, 2015
    Inventors: Benny Bang-Andersen, Arne Mork, Nicholas Moore, Tine Bryan Stensbol
  • Publication number: 20140377363
    Abstract: This disclosure relates to a method of treating a disease selected from the group consisting of affective disorders, depression, major depressive disorder, anxiety, general anxiety disorder, social anxiety disorder, obsessive compulsive disorder, panic disorder, and panic attacks. The method includes administering a therapeutically effective amount of Compound I or a pharmaceutically acceptable salt thereof to a patient in need thereof, in which Compound I is 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: Benny Bang-Andersen, Arne Mork, Nicholas Moore, Tine Bryan Stensbol
  • Publication number: 20140315921
    Abstract: This disclosure relates to 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or a pharmaceutically acceptable salt thereof in a crystalline form.
    Type: Application
    Filed: July 9, 2014
    Publication date: October 23, 2014
    Inventors: Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Rene Holm, Tine Bryan Stensbol, Nicholas Moore
  • Publication number: 20140248356
    Abstract: 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
    Type: Application
    Filed: April 1, 2014
    Publication date: September 4, 2014
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Arne Mork, Nicholas Moore, Tine Bryan Stensbol
  • Publication number: 20140248355
    Abstract: 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
    Type: Application
    Filed: April 1, 2014
    Publication date: September 4, 2014
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Arne Mork, Nicholas Moore, Tine Bryan Stensbol
  • Patent number: 8722684
    Abstract: 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: May 13, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Rene Holm, Tine Bryan Stensbol, Nicholas Moore
  • Patent number: 8664225
    Abstract: The use of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine in the treatment of pain and residual symptoms in depression is provided.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: March 4, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Nicholas Moore, Tine Bryan Stensbol
  • Publication number: 20130266631
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine in a matrix at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate matrix formulations are provided within biodegradable polymers, this pain relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: April 5, 2012
    Publication date: October 10, 2013
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Danielle L. Clay, Nicholas A. Moore
  • Publication number: 20130197094
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of a TRPV1 compound (e.g., capsaicinoid compound) at or near a target site, one can relieve pain caused by diverse sources, including but not limited to, postoperative pain, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 1, 2013
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Nicholas A. Moore, Danielle L. Clay
  • Publication number: 20110201617
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: November 12, 2008
    Publication date: August 18, 2011
    Applicants: H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
    Inventors: Nicholas Moore, Marianne Dragheim, Aneil Batra, Jin Chon
  • Publication number: 20110009422
    Abstract: The use of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine in the treatment of pain and residual symptoms in depression is provided.
    Type: Application
    Filed: March 14, 2008
    Publication date: January 13, 2011
    Applicant: H Lundbeck A/S
    Inventors: Nicholas Moore, Tine Bryan Stensbol
  • Publication number: 20100297240
    Abstract: 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
    Type: Application
    Filed: June 15, 2007
    Publication date: November 25, 2010
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez De Diego, Rene Holm, Tine Bryan Stensbol, Lone Munch Ringgaard, Michael J. Mealy, Michael Harold Rock, Jorgen Brodersen, Morten Jorgensen, Nicholas Moore